Author:
Prince HM,Rischin D,Toner GC,Seymour JF,Blakey D,Gates P,Eerhard S,Chapple P,Quinn M,Brettell M,Juneja S,Wolf M,Januszewicz EH,Richardson G,Scarlett J,Briggs P
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference32 articles.
1. Sledge GW, Antman KH . Progress in chemotherapy for metastatic breast cancer Semin Oncol 1996 19: 317–332
2. Antman KH, Rowlings PA, Vaughan WP et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America J Clin Oncol 1997 15: 1870–1879
3. Peters WP, Jones RB, Vredenburgh J et al. A large, prospective, randomized trial of high-dose combination alkylating agents (CPB) with autologous cellular support (ABMS) as consolidation for patients with metastatic breast cancer achieving a complete remission after intensive doxorubicin-based induction therapy (AFM) Proc Am Soc Clin Oncol 1996 15: 121, Abstr. 149
4. Stadtmauer EA, O'Neill LJ, Goldstein LJ et al. Conventional-dose chemotherapy compared to high-dose chemotherapy plus autologous hematopoietic stem cell transplantation for metastatic breast cancer New Engl J Med 2000 342: 1069–1076
5. Lotz JP, Cure H, Janvier M et al. High-dose chemotherapy with hematopoietic stem cells transplantation for metastatic breast cancer: Results of the French protocol PEGASE 04 Proc Am Soc Clin Oncol 1999 18: 43a, Abstr. 161
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献